Cargando…
Antibacterial activity of high-dose nitric oxide against pulmonary Mycobacterium abscessus disease
INTRODUCTION: Mycobacterium abscessus is an emerging pulmonary pathogen with limited treatment options. Nitric oxide (NO) demonstrates antibacterial activity against various bacterial species, including mycobacteria. In this study, we evaluated the effect of adjunctive inhaled NO therapy, using a no...
Autores principales: | Bogdanovski, Kristijan, Chau, Trisha, Robinson, Chevalia J., MacDonald, Sandra D., Peterson, Ann M., Mashek, Christine M., Wallin, Windy A., Rimkus, Mark, Montgomery, Frederick, Lucas da Silva, Joas, Gupta, Shashank, Ghaffari, Abdi, Zelazny, Adrian M., Olivier, Kenneth N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Microbiology Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656188/ https://www.ncbi.nlm.nih.gov/pubmed/33195983 http://dx.doi.org/10.1099/acmi.0.000154 |
Ejemplares similares
-
Amikacin exposure and susceptibility of macrolide-resistant Mycobacterium abscessus
por: Daniel-Wayman, Shelby, et al.
Publicado: (2019) -
Dissecting the antibacterial activity of oxadiazolone-core derivatives against Mycobacterium abscessus
por: Madani, Abdeldjalil, et al.
Publicado: (2020) -
Antibacterial activity of the novel oxazolidinone contezolid (MRX-I) against Mycobacterium abscessus
por: Gao, Shan., et al.
Publicado: (2023) -
Antibacterial activity of the novel compound Sudapyridine (WX-081) against Mycobacterium abscessus
por: Nie, Wenjuan, et al.
Publicado: (2023) -
Canaliculitis por Mycobacterium abscessus subsp. abscessus
por: Tello, María Nieves Carmona, et al.
Publicado: (2021)